Increase in -glutamyltransferase level and development of established cardiovascular risk factors and diabetes in Japanese adults

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 5, 2009, Pages 411-418

  Jimba, Sachiyo ^a   Nakagami, Tomoko ^a   Oya, Junko ^a   Wasada, Taro ^b   Endo, Yasuhiro ^c   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Totsuka Royal Clinic   (Japan)

^c Saitama ken Saiseikai Kurihashi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ASIAN; BIOLOGICAL MODEL; BLOOD; ETHNOLOGY; GLUCOSE BLOOD LEVEL; INCIDENCE; JAPAN; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS; TIME; UPREGULATION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES; UP-REGULATION;

EID: 70350343555     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0082     Document Type: Article

References (31)

1. Skinner HA, Holt S, Schuller R, Roy J, Israel Y. Identifi cation of alcohol abuse using laboratory tests and a history of trauma. Ann Intern Med 1984;101:847-851.
2. Lee DH, Blomhoff R, Jacobs Jr DR. Is serum gamma-glutamyltranseferase a marker of oxidative stress? Free Radic Res 2004;38:535-539.
3. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamiyl transpeptidase and the metabolic syndrome. J Int Med 2000;248:230-238.
4. Kim DJ, Noh JH, Cho NH, Lee BW, Choi YH, Jung JH, Min YK, Lee MS, Lee MK, Kim KW. Serum ?-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet Med 2005;22:1134-1140.
5. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum ?-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003;254:287-295. (Pubitemid 37070231)
6. Nakanishi N, Suzuki K, Tatara K. Serum ?-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middleaged Japanese. Diabetes Care 2004;27:1427-1432. (Pubitemid 38679993)
7. Lee DH, Jacobs Jr DR, Gross M, Kiefe C, Roseman J, Lewis C, Steffers M. ?-Glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003, 49:1358-1366. (Pubitemid 36900623)
8. Wannamethee G, Ebrahim S, Shaper AG. Gammaglutamyltransferase: Determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
9. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-737.
10. Hanley AJ, Wiliams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM. Elevation in markers of liver injury and risk of type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetes 2004;53:2623-2632.
11. Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 2004;53:2855-2860.
12. Wannamethee SG, Shaper AG, Lennon L, Whincup P. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 2005;28:2913-2918.
13. André P, Balkau B, Born C, Royer B, Wilpart E, Charles MA, Eschwèqe E. Hepatic markers and development of type 2 diabetes in middle aged men and women: A three-year follow-up study: The D.E.S.I.R. study. Diabetes Metab 2005;31:542-550.
14. André P, Balkau B, Vol S, Charles MA, Eschwège E; The D.E.S.I.R. study group. Gamma-glutamyltransferase activity and development of the metabolic syndrome (IDF defi nition), in middle-aged men women: The D.S.I.R. cohort. Diabetes Care 2007;30:2355-2361.
15. Spiro HM. Primary structural disorders. In Spiro HM (ed.): Clinical Gastroenterology. New York: McGraw-Hill; 1993:1059-1108.
16. Malnick SD, Beergabel M, Knobler H. Non-alcoholic fatty liver: A common manifestation of a metabolic disorder. QJ Med 2003;96:699-709.
17. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, Wasada T. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005;22:1141-1145.
18. Friedewald WT, Levi RI, Fredrickson DS. Estimation of the contentration of low density lipoproteins cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1990;36:36-42.
19. World Health Organization: Report of a WHO consultation. Definition, Diagnosis and Classifi cation of Diabetes Mellitus. Part 1: Defi nition, Diagnosis and Classifi cation of Diabetes Mellitus. Geneva: World Health Organization; 1999: WHO/ NCD/NCS/99.2.
20. The Japanese Society of Internal Medicine. Guideline for diagnosis of metabolic syndrome. Jpn J Med 2005;94:188-203 (in Japanese).
21. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M. Goals of dyslipidemia management-Executive summary of Japan Atherosclerosis Society (JAS) Guideline for diagnosis and prevention of atherosclerotic cardiovascular disease for Japanese. J Atheroscler Thromb 2007;14:209-212.
22. André P, Balkau B, Born C, Charles MA, Eschwège E. D.E.S.I.R. study group. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middleaged men and women: The D.E.S.I.R. cohort. Diabetologia 2006, 49:2599-2603.
23. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC. Relationship between ?-glutamyltransferase, lipids and lipoprotein(a) in the general population. Clin Chim Acta 2007;384:163-166. (Pubitemid 47248650)
24. Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A. ?-Lipoprotein- and LDL-associated serum gamma- glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 2006;186:80-85.
25. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, Pompella A. Images in cardiovascularmedicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004;109:1440.
26. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mod Med 2001;79:21-29.
27. Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G, Dichiara MA, Melino G, Cecala MG. Central obesity and hypertension: Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens 1994;7:314-320.
28. Orie NN, Zidek W, Tepel M. Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 1999;12:1169-1174.
29. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51:1889-1895. (Pubitemid 34564303)
30. Sebastian-Gambaro MA, Liron-Hernandez FJ, Fuentes-Arderiu X. Intra- and inter-individual biological variability data bank. Eur J Clin Chem Biochem 1997;35:845-852.
31. Puavilai G, Chanprasertyotin S, Sriphradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classifi cation of Diabetes Mellitus (ADA), 1998 WHO Consultation criteria, and 1985 WHO criteria. Diabetes Res Clin Pract 1999;44:21-26.